PMC Co-directors Drs. Jason Karlawish and Dave Wolk will discuss the FDA’s decision on the drug lecanemab and what the decision means for patients and families.
Back to All Events
Earlier Event: January 18
IMPACT Collaboratory, "Words Matter: Nomenclature in Dementia"
Later Event: February 8
Grand Round, "Amyloid on the Brain, Alzheimer’s on the Mind"